US$1 billion acquisition financing for Teva Pharmaceuticals

Bank Hapoalim
2008 - 2009

Our attorneys represented Bank Hapoalim in its US$1 billion loan to Teva Pharmaceuticals, in connection with its acquisition of Barr Pharmaceuticals.  Our attorneys regularly represent Bank Hapoalim in its US lending activities, including both secured and unsecured credit facilities for borrowers in a wide variety of industries.


Email Disclaimer